Stomach & Esophageal Cancer Linked to Heartburn Reflux Drugs

Proton Pump Inhibitors (PPI) Linked to Stomach & Esophageal Cancer

Long-term use of proton pump inhibitors like Nexium and Prilosec could lead to an increased risk of stomach cancer. That’s the news out of Gut medical journal, an academic publication that focuses on stomach health research. While stomach cancer is somewhat rare, those taking proton pump inhibitors may double their chances of being diagnosed with the deadly disease. More alarmingly, those taking the medications for more than three years increase their odds of developing stomach cancer by eightfold.

You may be owed compensation have you ever taken a Proton Pump Inhibitor (PPI) drug, such as Nexium, Prilosec, or Prevacid, for reflux or heartburn? Were you diagnosed with stomach, gastric, or esophageal cancer after using a PPI?

Increased Risk of Stomach & Esophageal Cancers

Proton pump inhibitor (PPI) drugs, such as Nexium, Prilosec, and Prevacid are popular medications used to treat gastroesophageal reflux disease (GERD). A recent study suggests that the long-term use of PPIs may increase your risk of developing stomach & esophageal cancer.

PPI Stomach Cancer & Esophageal Cancer Lawsuits

If you’ve taken a proton pump inhibitor, such as Nexium, Prilosec, or Prevacid, and you were later diagnosed with stomach cancer, contact us about a potential lawsuit. The consultation is free, and our no fee promise means you don’t owe us any legal fees unless we settle or win your case. Call now for more information 877-544-5323.


Popular Reflux Drugs May Increase Stomach Cancer Risk
Are you one of the millions of Americans taking prescription medication for heartburn or acid reflux? If so, you could be at an increased risk of developing stomach cancer. New research has revealed
Heartburn Drugs Linked to Stomach Cancer
Heartburn Drugs Linked to Esophageal Cancer